Publications list for Professor Iain L. Campbell

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Hsu, M., Frausto, R., Rose-John, S., Campbell, I. (2015), Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M. Glia. 63(1), 132-141. [Abstract]


  • Almolda, B., Villacampa, N., Manders, P., Hidalgo, J., Campbell, I., Gonzalez, B., Castellano, B. (2014), Effects of astrocyte-targeted production of interleukin-6 in the mouse on the host response to nerve injury. Glia. 62(7), 1142-1161. [Abstract]
  • Li, W., Hofer, M., Jung, S., Lim, S., Campbell, I. (2014), IRF7-DEPENDENT, TYPE I INTERFERON PRODUCTION INDUCES LETHAL IMMUNE-MEDIATED DISEASE IN STAT1 KO MICE INFECTED WITH LCMV. Journal of Virology. 88(13), 7578. [Abstract]
  • Van Belle, T., Pagni, P., Liao, J., Sachithanantham, S., Dave, A., Bel Hani, A., Manenkova, Y., Amirian, N., Yang, C., Morin, B., Zhang, H., Campbell, I., von Herrath, M. (2014), Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes. Journal of Autoimmunity. 55, 24¿32. [Abstract]
  • Campbell, I., Erta, M., Lim, S., Frausto, R., May, U., Rose-John, S., Scheller, J., Hidalgo, J. (2014), Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. The Journal of Neuroscience. 34(7), 2503-2513. [Abstract]
  • Getts, D., Terry, R., Getts, M., Deffrasnes, C., Müller, M., van Vreden, C., Ashhurst, T., Chami, B., McCarthy, D., Wu, H., Ma, J., Martin, A., Shae, L., Witting, P., Kansas, G., Kühn, J., Hafezi, W., Campbell, I., Reilly, D., Say, J., Brown, L., White, M., Cordwell, S., Chadban, S., Thorp, E., Bao, S., Miller, S., King, N. (2014), Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine. 6(219), 219ra7. [Abstract]
  • Millington, C., Sonego, S., Karunaweera, N., Rangel, A., Aldrich-Wright, J., Campbell, I., Gyengesi, E., Munch, G. (2014), Chronic Neuroinflammation in Alzheimer's Disease: New Perspectives on Animal Models and Promising Candidate Drugs. BioMed Research International. 2014, 309129. [Abstract]
  • Noçon, A., Ip, J., Terry, R., Lim, S., Getts, D., Mülller, M., Hofer, M., King, N., Campbell, I. (2014), The bacteriostatic protein lipocalin 2 is induced in the central nervous system of mice with west Nile virus encephalitis. Journal of Virology. 88(1), 679-689. [Abstract]


  • Roberts, K., Zeineddine, R., Corcoran, L., Li, W., Campbell, I., Yerbury, J. (2013), Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia. 61(3), 409-419. [Abstract]
  • Li, W., Hofer, M., Noçon, A., Manders, P., Campbell, I. (2013), Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice. Virology. 439(2), 152-162. [Abstract]
  • Giralt, M., Ramos, R., Quintana, A., Ferrer, B., Erta, M., Castro-Freire, M., Comes, G., Sanz, E., Unzeta, M., Pifarré, P., García, A., Campbell, I., Hidalgo, J. (2013), Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6. Glia. 61(4), 587-600. [Abstract]
  • Hofer, M., Campbell, I. (2013), Type I interferon in neurological disease-The devil from within. Cytokine & Growth Factor Reviews. 24(3), 257-267. [Abstract]
  • Zimmermann, J., Krauthausen, M., Hofer, M., Heneka, M., Campbell, I., Müller, M. (2013), CNS-Targeted Production of IL-17A Induces Glial Activation, Microvascular Pathology and Enhances the Neuroinflammatory Response to Systemic Endotoxemia. PloS One. 8(2), e57307. [Abstract]


  • Getts, D., Terry, R., Getts, M., Müller, M., Rana, S., Deffrasnes, C., Ashhurst, T., Radford, J., Hofer, M., Thomas, S., Campbell, I., King, N. (2012), Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. Journal of Neuroinflammation. 9(1), 246. [Abstract]
  • Hofer, M., Li, W., Manders, P., Terry, R., Lim, S., King, N., Campbell, I. (2012), Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. Journal of Virology. 86(12), 6932-6946. [Abstract]
  • Terry, R., Getts, D., Deffrasnes, C., van Vreden, C., Campbell, I., King, N. (2012), Inflammatory monocytes and the pathogenesis of viral encephalitis. Journal of Neuroinflammation. 9, 270. [Abstract]
  • Minten, C., Terry, R., Deffrasnes, C., King, N., Campbell, I. (2012), IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS. PloS One. 7(11), e49851. [Abstract]


  • Krauthausen, M., Ellis, S., Zimmermann, J., Sarris, M., Wakefield, D., Heneka, M., Campbell, I., Müller, M. (2011), Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12. The American Journal of Pathology. 179(5), 2346-2359. [Abstract]
  • Ip, J., Noçon, A., Hofer, M., Lim, S., Müller, M., Campbell, I. (2011), Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. Journal of Neuroinflammation. 8, 124. [Abstract]


  • Campbell, I., Hofer, M., Pagenstecher, A. (2010), Transgenic models for cytokine-induced neurological disease. Biochimica et biophysica acta. 1802(10), 903-17. [Abstract]
  • Müller, M., Carter, S., Hofer, M., Campbell, I. (2010), The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum. Neuropathology and applied neurobiology. 36(5), 368-87. [Abstract]
  • Ellis, S., Gysbers, V., Manders, P., Li, W., Hofer, M., Müller, M., Campbell, I. (2010), The Cell-Specific Induction of CXC Chemokine Ligand 9 Mediated by IFN-{gamma} in Microglia of the Central Nervous System Is Determined by the Myeloid Transcription Factor PU.1. Journal of immunology (Baltimore, Md. : 1950). 185(3), 1864-77. [Abstract]
  • Hofer, M., Li, W., Lim, S., Campbell, I. (2010), The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. The Journal of neuroscience : the official journal of the Society for Neuroscience. 30(3), 1149-1157. [Abstract]
  • Thompson, C., Hofer, M., Campbell, I., Holmes, A. (2010), Community dynamics in the mouse gut microbiota: a possible role for IRF9-regulated genes in community homeostasis. PLoS One. 5(4), e10335. [Abstract]


  • Feuer, R., Ruller, C., An, N., Tabor-Godwin, J., Rhoades, R., Maciejewski, S., Pagarigan, R., Cornell, C., Crocker, S., Kiosses, W., Pham-Mitchell, N., Campbell, I., Whitton, J. (2009), Viral persistence and chronic immunopathology in the adult CNS following coxsackievirus infection during the neonatal period. Journal of virology. 83(18), 9356-69. [Abstract]
  • Quintana, A., Müller, M., Frausto, R., Ramos, R., Getts, D., Sanz, E., Hofer, M., Krauthausen, M., King, N., Hidalgo, J., Campbell, I. (2009), Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. Journal of Immunology. 183(3), 2079-2088. [Abstract]